NEKTAR THERAPEUTICS Quarterly Weighted Average Number of Shares Outstanding, Basic from Q3 2013 to Q2 2024

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
Nektar Therapeutics quarterly/annual Weighted Average Number of Shares Outstanding, Basic history and growth rate from Q3 2013 to Q2 2024.
  • Nektar Therapeutics Weighted Average Number of Shares Outstanding, Basic for the quarter ending June 30, 2024 was 209M shares, a 10.1% increase year-over-year.
  • Nektar Therapeutics annual Weighted Average Number of Shares Outstanding, Basic for 2023 was 190M shares, a 1.53% increase from 2022.
  • Nektar Therapeutics annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 187M shares, a 2.1% increase from 2021.
  • Nektar Therapeutics annual Weighted Average Number of Shares Outstanding, Basic for 2021 was 183M shares, a 2.64% increase from 2020.
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 209M +19.2M +10.1% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-09
Q1 2024 195M +5.87M +3.11% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-10
Q4 2023 190M +2.86M +1.53% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-05
Q3 2023 190M +2.77M +1.47% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-08
Q2 2023 190M +2.86M +1.53% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-09
Q1 2023 189M +3.03M +1.63% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-10
Q4 2022 187M +3.84M +2.1% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-05
Q3 2022 188M +3.53M +1.92% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-08
Q2 2022 187M +4.1M +2.25% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-09
Q1 2022 186M +4.48M +2.47% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-10
Q4 2021 183M Oct 1, 2021 Dec 31, 2021 10-K 2024-03-05
Q3 2021 184M +5.02M +2.8% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-04
Q2 2021 183M +4.37M +2.45% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-05
Q1 2021 181M Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-06
Q3 2020 179M +3.69M +2.1% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-05
Q2 2020 178M +3.78M +2.16% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-06
Q3 2019 175M +2.7M +1.57% Jul 1, 2019 Sep 30, 2019 10-Q 2019-11-07
Q2 2019 175M +3.17M +1.85% Apr 1, 2019 Jun 30, 2019 10-Q 2019-08-09
Q3 2018 173M +16.3M +10.4% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-07
Q2 2018 171M +16M +10.3% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-09
Q3 2017 156M +19.3M +14.1% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-08
Q2 2017 155M Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-09
Q3 2016 137M +4.46M +3.37% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-08
Q1 2016 136M +4.43M +3.38% Jan 1, 2016 Mar 31, 2016 10-Q 2016-05-04
Q3 2015 133M +5.13M +4.02% Jul 1, 2015 Sep 30, 2015 10-Q 2015-11-06
Q1 2015 131M +7.82M +6.33% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-04
Q3 2014 128M +11.7M +10.1% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-06
Q1 2014 124M Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-01
Q3 2013 116M Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-07
* An asterisk sign (*) next to the value indicates that the value is likely invalid.